Apolipoprotein E-Genotyping and MRI Study for Alzheimer’s Disease Classification: PCR-RFLP and Restricted Enzymes AfIII for RS429358 and HaeII for RS7412

NH Mohad Azmi,S Suppiah,NSN Ibrahim,B Ibrahim,VP Seriramulu,M Mohamad,T Karuppiah,NF Omar,N Ibrahim,RM Razali,NH Harrun,H Sallehuddin,N Syed Nasser,AD Piersson
DOI: https://doi.org/10.1101/2024.01.04.24300735
2024-01-04
Abstract:The most common type of dementia in neurodegenerative diseases is Alzheimer’s disease (AD), a progressive neurological illness that causes memory loss. Neurophysiological tests, including the montreal cognitive assessment (MoCA), mini-mental state examination (MMSE), and clinical dementia rating (CDR) scores, are used to identify AD. Neuroimaging studies T1-weighted MRI scans assessed brain structural abnormalities. AD patients had grey matter volume (GMV) loss in brain structures when structural MRI data were analysed using voxel-based morphometry (VBM). Neuroimaging studies using resting state functional MRI (rs-fMRI)-blood oxygen level dependent (BOLD) sequence for brain imaging were processed using the seed-based analysis (SBA) method to analyse functional connectivity (FC) in the default mode network (DMN), sensorimotor network (SEN), executive control network (ECN), language network (LN), visuospatial network (VN), and salience network (SAN). Late-onset AD can be studied using the apolipoprotein E gene (ApoE). ApoE has four alleles with LOAD patients having either a homozygous or heterozygous genotype of these alleles. The genotypes, particularly ApoE ε4, are associated with a more significant risk for AD pathogenesis. The combination of genotyping and MRI neuroimaging is a promising avenue for research that starts with protocol optimisation. Objective: to differentiate changes in structural brain volumetric and rs-fMRI functional connectivity strength with the diagnosis of AD and HC by combining ApoE ε4 genetic variations.
Neurology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to distinguish the differences in brain structural volume changes and resting - state functional magnetic resonance imaging (rs - fMRI) functional connectivity strength between Alzheimer's disease (AD) patients and healthy control groups (HC) by combining apolipoprotein E (ApoE) genotyping and magnetic resonance imaging (MRI) techniques. Specifically, the study focuses on the following points: 1. **Genotyping**: Use the polymerase chain reaction - restriction fragment length polymorphism (PCR - RFLP) method to detect the APOE ε4 allele and determine its distribution in AD patients. APOE ε4 is considered an important risk factor for late - onset Alzheimer's disease (LOAD). 2. **Structural brain imaging analysis**: Through T1 - weighted MRI scans and voxel - based morphometry (VBM) analysis, evaluate the differences in brain gray matter volume (GMV) between AD patients and HC. The study pays special attention to GMV changes in regions such as the prefrontal lobe and anterior cingulate gyrus. 3. **Functional brain imaging analysis**: Use resting - state functional magnetic resonance imaging (rs - fMRI) combined with seed - based analysis (SBA) methods to analyze the functional connectivity changes in the default mode network (DMN), sensorimotor network (SEN), executive control network (ECN), language network (LN), visuospatial network (VN), and saliency network (SAN). 4. **Comprehensive analysis**: Explore the relationship between APOE ε4 allele - carrying status and brain structure and function changes, aiming to provide potential biomarkers for the early diagnosis of AD. In summary, the main purpose of this study is to explore the impact of APOE ε4 gene variation on the brain structure and function of AD patients by combining genotyping and neuroimaging techniques, thereby providing new ideas and methods for the early identification and diagnosis of AD.